Our findings showed that the hepatic expression levels of lipogenic genes SREBP-1c, ChREBP, CD36, and FASN are elevated in response to WD, which contributes to de novo lipid synthesis (Figure 2E). The gene discussed is FASN; the disease is Wilson disease.